Boston Scientific (BSX) Short-term Investments (2019 - 2020)
Boston Scientific's (BSX) quarterly Short-term Investments came in at $146.0 million in Q3 2020, down 9.32% quarter-over-quarter from $161.0 million in Q2 2020.
Powered by 
Analysis
Boston Scientific (BSX) Short-term Investments (2019 - 2020) Analysis & Trends
Boston Scientific has disclosed Short-term Investments across 2 years of filings, most recently posting $146.0 million for Q3 2020.
- In Q3 2020, Short-term Investments changed N/A year-over-year to $146.0 million; the TTM figure through Sep 2020 stood at $146.0 million (changed N/A YoY), while the FY2019 annual figure was $105.0 million, changed N/A from the prior year.
- Short-term Investments came in at $146.0 million for Q3 2020 at Boston Scientific, down from $161.0 million in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $218.0 million in Q1 2020 to a low of $105.0 million in Q4 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 18.00 Bn | 17.59 Bn | 1.54 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2020 | 146.00 Mn |
| Jun 30, 2020 | 161.00 Mn |
| Mar 31, 2020 | 218.00 Mn |
| Dec 31, 2019 | 105.00 Mn |